Alex Kaoukhov

Dr Alex Kaoukhov is Chief Medical Officer of ASLAN Pharmaceuticals.

Dr Kaoukhov has more than 20 years of global drug development experience in the US and Europe. He most recently served as Head of Clinical Development, Senior Vice President at Bioniz Therapeutics where he established and managed a team responsible for the development of therapeutic assets for the treatment of skin and gastrointestinal autoimmune diseases.

Prior to joining Bioniz, Dr Kaoukhov was Head of Global Development at Almirall where he oversaw global clinical and non-clinical development programs in addition to contributing to business development activities such as the in-licensing of lebrikizumab for Europe.

Prior to Almirall, Dr Kaoukhov served as Head of Global Development at Allergan in the US, where he oversaw the medical dermatology pipeline, and has held senior clinical development roles at Novartis and Galderma. During his career, Alex has designed and led large clinical trials, secured several product approvals for global programs and has led the development of numerous innovative early-stage programs.

Dr Kaoukhov earned an MD Degree with Honors from First Moscow State Medical University and was trained in dermatology at Saint Louis Hospital in Paris.